Nir Sassi - Jan 22, 2024 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Financial Officer
Signature
/s/ Nir Sassi
Stock symbol
INDP
Transactions as of
Jan 22, 2024
Transactions value $
$0
Form type
4
Date filed
1/23/2024, 04:15 PM
Previous filing
Jan 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jan 22, 2024 Common Stock 40K $1.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027.